Spurs' Victor Wembanyama: Undergoes surgery on blood clot
Rotowire
Head coach of the French National team, Frederic Fauthoux, said Thursday that Wembanyama underwent surgery on the deep vein thrombosis in his right shoulder and is feeling fine, Jeff Garcia of KENS 5 San Antonio reports.
Wembanyama was ruled out for the remainder of the 2024-25 NBA season during the All-Star break due to the deep vein thrombosis. However, Fauthoux is optimistic that the superstar could return for the FIBA EuroBasket Qualifiers this summer. The Spurs expect to have Wembanyama back by the start of the 2025-26 season, and this update from Fauthoux suggests that he'll be ready for the Spurs' Opening Night, barring any setbacks. The second-year big man finished the 2024-25 campaign with averages of 24.3 points, 11.0 rebounds, 3.8 blocks, 3.7 assists, 3.1 three-pointers and 1.1 steals in 33.2 minutes per contest over his 46 regular-season appearances.
Spurs' Victor Wembanyama: Deep vein thrombosis ends season
Rotowire
Wembanyama will not play for the remainder of the 2024-25 season due to deep vein thrombosis in his right shoulder, Shams Charania of ESPN reports.
According to Charania, the Spurs believe the blood clot is isolated. Still, it's a serious medical diagnosis, and the team will have Wembanyama sit out the remainder of the season for his safety and to get more information. Wembanyama's season ends with averages of 24.3 points, 11.0 rebounds, 3.7 assists, 3.8 blocks and 1.1 steals -- numbers worthy of earning the league's Defensive Player of the Year award, though Wembanyama won't be eligible for the honor due to the amount of games he'll miss. The Spurs will presumably fill in the center spot with a combination of Sandro Mamukelashvili, Jeremy Sochan and Charles Bassey (knee). The organization may also make a move to pick up a free-agent center.
2:58
0:28
0:49
0:57
1:12
0:41
2:21
1:03
2:45
0:46
1:21
1:03
